Related Experiment Videos
Churg-Strauss syndrome with renal involvement: a case report
A Kitoh1, S Nobuhara, K Takahashi
1Department of Dermatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
The Journal of Dermatology
|April 26, 2001
Summary
Churg-Strauss syndrome, a rare condition, can affect the kidneys. This case study shows that renal involvement, including proteinuria and hematuria, improved with steroid treatment, suggesting it may be more common than previously thought.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Churg-Strauss syndrome (CSS), also known as eosinophilic granulomatosis with polyangiitis (EGPA), is a rare systemic vasculitis characterized by asthma, eosinophilia, and granulomatous inflammation.
- Renal involvement in CSS is often underrecognized, with varying degrees of kidney damage reported.
Observation:
- A 51-year-old woman presented with abdominal pain, diarrhea, and purpura, indicative of systemic vasculitis.
- Diagnostic criteria for CSS were met, including asthma history, marked eosinophilia, elevated IgE levels, and characteristic skin biopsy findings.
- Initial assessment revealed impaired renal function (creatinine clearance 43.3 ml/min) with proteinuria and microscopic hematuria.
Findings:
- The patient's renal abnormalities, including proteinuria and hematuria, demonstrated significant improvement following systemic corticosteroid therapy.
- Histopathological examination of the purpuric lesions confirmed eosinophilic infiltration and vasculitis, consistent with CSS.
- The case highlights the potential for significant renal dysfunction in CSS patients.
Implications:
- This case suggests that renal involvement may be a more frequent manifestation of Churg-Strauss syndrome than previously appreciated.
- Early recognition and prompt treatment with corticosteroids are crucial for managing renal complications in CSS.
- Further research is warranted to elucidate the prevalence and long-term renal outcomes in patients with CSS.